SMIM30 promotes HCC progression by interacting with the tyrosine kinases SRC/YES1 to activate the mitogen-activated protein kinase (MAPK) pathway, thereby modulating cell proliferation and migration [84]. The gene discussed is SMIM30; the disease is hepatocellular carcinoma.